Inhibrx, Inc. (INBX)
NASDAQ: INBX · IEX Real-Time Price · USD
14.19
-1.51 (-9.62%)
At close: Jun 17, 2024, 4:00 PM
14.10
-0.09 (-0.63%)
After-hours: Jun 17, 2024, 7:07 PM EDT

Inhibrx Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022
Revenue
1.631.32
Revenue Growth (YoY)
24.26%-
Gross Profit
1.631.32
Selling, General & Admin
24.2515.04
Research & Development
130.13101.6
Operating Expenses
154.38116.64
Operating Income
-152.75-115.32
Other Expense / Income
2.21-0
Pretax Income
-154.96-115.32
Income Tax
00
Net Income
-154.96-115.33
Shares Outstanding (Basic)
13-
Free Cash Flow
-133.6-91.5
Free Cash Flow Per Share
-9.98-
Gross Margin
100.00%100.00%
Operating Margin
-9348.04%-8769.81%
Profit Margin
-9483.72%-8769.96%
Free Cash Flow Margin
-8176.25%-6957.95%
EBITDA
-152.01-112.48
EBITDA Margin
-9302.63%-8553.31%
Depreciation & Amortization
2.962.85
EBIT
-154.96-115.32
EBIT Margin
-9483.54%-8769.73%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).